Burnaby firm poised to strike Ebola virus
Hospital staff carry a coffin containing the body of Dinarosa Belleri, the fifth Italian nun from the Sisters of the Poor order to die from the deadly Ebola virus, to the cemetery in Kitwit May 14, 2009. (FILE PHOTO)
A company headquartered in Burnaby says it has given a first dose of a treatment to help battle the Ebola virus.
In a news release, Tekmira Pharmaceuticals said it dosed its first human subject during a clinical trial of TKM-Ebola.
The anti-Ebola viral therapy is being developed with a USD $140-million contract with the United States Department of Defence.
The company said the treatment helped create 100% protection from a lethal dose of the virus.
With occasional outbreaks in Africa, the World Health Organization said those hit with the virus can experience fever, internal bleeding and weakness, and is often fatal.